CD4 IgG

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug NameCD4 IgG
Drug Alias NameCD4 ImmunoadhesinCD4 AntigensHybrid CD4rsCD4 IgGRecombinant CD4 Immunoglobulin G +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsPurpura, Thrombocytopenic, IdiopathicHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenentech IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsPurpura, Thrombocytopenic, IdiopathicHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A